Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Sun Yat-sen University · Sun Yat-sen University Cancer Center · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
165
total citations
- FWCI
- 78.53
- Percentile
- 100%
- References
- 34
Citations per year
Authors
55- XLXu LiuCorresponding
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- YZYuan Zhang
Sun Yat-sen University, Sun Yat-sen University Cancer Center
- KYKun-Yu Yang
Union Hospital, Huazhong University of Science and Technology
- NZNing Zhang
First People's Hospital of Foshan
- FJFeng Jin
Guiyang Medical University
Topics & keywords
Topics
Keywords
- Nasopharyngeal carcinoma
- Open label
- Medicine
- Chemoradiotherapy
- Oncology
- Internal medicine
- Randomized controlled trial
- China
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.